Over the past 12 months, Canopy Growth’s CGC shares have fallen by half.
The Analyst
Bank of America Merrill Lynch’s Christopher Carey reiterated a Neutral rating on Canopy Growth with a $23 price objective.
The Thesis
The risk-reward profile for Canopy's second-quarter looks much better than it did six weeks ago, Carey said in a Wednesday note. (See his track record here.)
Bank of America downgraded the stock Sept. 27.
The analyst predicts the company will reveal its new CEO when it reports second-quarter results Nov. 14.
That development, together with recently lowered estimates, could form a low bar, he said.
“Reiterate Neutral, on near-term execution risks and potentially lofty Street estimates, balanced by an industry leading balance sheet.”
The second-quarter consensus sales estimate is CA$102 million ($77.4 million) versus CA$97 million in the prior quarter, Carey said.
Bank of America is expecting a figure beneath the Street estimate: CA$94 million.
The Street's out-year estimates present a “best case scenario,” the analyst said.
"While we think that setup has improved for FQ220, we view sustainable upside in Canopy shares as challenging, particularly against a backdrop of Street estimates that we think are too high."
Price Action
Canopy Growth shares were up 0.7% at $20 at the time of publication.
Related Links:
Cannabis Stock Gainers And Losers From November 5, 2019
Large Option Trader Betting On Canopy Growth Bounce Ahead Of Earnings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.